Morningstar US Small Growth Rating $13.91 0.00 (0.00%) As of 10/9/2025 Add Compare Share Share Ratings Stock AnalysisChartRatingsBuy This Stock Morningstar US Small Growth Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MSGR Aggregate RatingHold 2.50Holdings in MSGR have an aggregate rating of Hold based on 296 analyst ratings issued in the past year covering 21 companies (90.8% of the portfolio).MSGR Aggregate Price Target$13.91High Prediction$13.91Average Prediction$13.91Low Prediction$13.91Holdings in MSGR have an aggregate price target of $13.91 and a range of $13.91 to $13.91 covering 21 companies (90.8% of the portfolio).MSGR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Morningstar US Small Growth Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 MSGR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.06%VRTXVertex Pharmaceuticals$412.94-1.9%4.7847 of 5 stars2.62$494.43 19.7%29Positive NewsAnalyst Forecast7.99%SCLXScilex$17.44-1.4%2.0943 of 5 stars2.20$455.00 2,508.9%5Analyst Forecast7.01%ARCTArcturus Therapeutics$19.34-1.8%2.8748 of 5 stars2.78$50.57 161.6%9Analyst Forecast6.62%ALNYAlnylam Pharmaceuticals$455.84-0.2%4.0125 of 5 stars2.79$448.04 -1.7%29Analyst Forecast6.44%MRNAModerna$27.75+0.8%4.3074 of 5 stars2.00$41.81 50.7%23Analyst Forecast6.17%BNTXBioNTech$104.31-0.2%2.4157 of 5 stars2.64$134.32 28.8%14Positive News5.97%SRPTSarepta Therapeutics$22.94-0.8%4.574 of 5 stars2.03$34.42 50.0%29Analyst Forecast5.78%PTCTPTC Therapeutics$66.08+0.1%3.3953 of 5 stars2.53$69.00 4.4%15Analyst ForecastInsider Trade4.94%MRVIMaravai LifeSciences$3.34+1.3%3.3535 of 5 stars2.08$5.22 56.1%124.29%NTLAIntellia Therapeutics$25.05-1.6%3.8952 of 5 stars2.52$27.95 11.6%21Analyst ForecastGap Up4.24%IONSIonis Pharmaceuticals$70.08-0.3%3.4955 of 5 stars2.80$78.28 11.7%20Trending NewsAnalyst ForecastInsider Trade3.19%RNAAvidity Biosciences$50.59-0.4%2.1706 of 5 stars2.95$68.32 35.1%20Analyst ForecastInsider Trade3.19%CVACCureVac$5.42+0.1%3.9331 of 5 stars2.17$6.83 26.2%6News CoverageAnalyst Forecast3.18%ARWRArrowhead Pharmaceuticals$35.69-1.0%4.0875 of 5 stars2.78$43.14 20.9%9Analyst Forecast2.95%ABUSArbutus Biopharma$4.23-1.0%1.6141 of 5 stars2.50$5.00 18.2%4News CoverageAnalyst Forecast2.59%DYNDyne Therapeutics$14.12-3.8%3.3444 of 5 stars2.88$34.07 141.3%17Analyst Forecast2.10%SGMOSangamo Therapeutics$0.72-2.3%2.2225 of 5 stars2.43$4.50 523.3%7News CoverageAnalyst Forecast1.84%STOKStoke Therapeutics$29.59-1.0%3.0773 of 5 stars3.00$27.43 -7.3%10Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.53%HLVXHilleVax$2.091.0272 of 5 stars2.00$2.00 -4.3%2Positive News1.52%PRQRProQR Therapeutics$2.51+0.2%2.002 of 5 stars2.89$8.00 219.2%9News CoveragePositive NewsAnalyst Forecast1.20%PEPGPepGen$4.80-4.6%3.4954 of 5 stars2.33$8.40 75.0%6Analyst Forecast This page (NYSEARCA:MSGR) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morningstar US Small Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share Morningstar US Small Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
